FDA panel votes in favor of Replimune’s melanoma treatment
- Posted on July 30, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
FDA panel votes in favor of Replimune’s melanoma treatment
Independent experts voted 10-3 despite regulators’ concern about the design of the company’s pivotal cancer trial.
